分子电机的旋转动力影响它们杀死癌细胞和诱导细胞信号的能力
Dallin Arnold1, Bowen Li1, Jacob L Beckham1
1Department of Chemistry, Rice University, 6100 Main Street, Houston, Texas 77005, United States.
Journal of the American Chemical Society
|June 17, 2025
概括
合成分子电机对细胞施加内部机械力. 用不同的功能组修改MM显示较小的组增强旋转,导致有效的细胞死亡和信号传递.
科学领域:
- 细胞力学
- 合成生物学
- 生物物理
背景情况:
- 化学剂是细胞操纵的传统工具.
- 机械力量,通常是外部的, 在细胞过程中至关重要.
- 合成分子电机 (MM) 提供内部机械力应用.
研究的目的:
- 研究MM的结构功能关系.
- 确定MM功能组如何影响生物结果.
- 探索细胞死亡和信号应用的MM.
主要方法:
- 合成了四种具有不同功能的MMs (甲基,异,三,).
- 使用密度函数理论 (DFT) 来计算旋转速率.
- 评估了MM在细胞杀死和信号传递方面的有效性.
主要成果:
- DFT计算预测的旋转率受到替代物大小的影响.
- 甲基化MM呈现出最快的旋转.
- 在诱导细胞死亡和信号方面,甲基化MM最有效.
结论:
- MMs通过单向旋转影响细胞环境.
- 来自MM的内部机械力量可以可控地诱导细胞活动.
- 对于生物应用来说,MM设计,特别是功能组,至关重要.
相关概念视频
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Destabilization of Microtubules
2.8K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.8K
Anaphase A and B
4.2K
Microtubules form through the end-to-end polymerization of tubulin heterodimers. Kinetochore microtubules originate from the spindle poles, and their plus-ends connect with the kinetochores on sister-chromatids. Ndc80 protein complexes, present on the kinetochore, form low-affinity links with the plus end of these kinetochore microtubules.
Plus-end depolymerization releases tubulin heterodimers from the terminal region of the microtubule. As tubulin subunits are lost, the Ndc80 complexes detach...
Plus-end depolymerization releases tubulin heterodimers from the terminal region of the microtubule. As tubulin subunits are lost, the Ndc80 complexes detach...
4.2K
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K


